ArticleCancer2021
Reply to COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.
Chiara Cattaneo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it